|
WO2021038572A1
|
|
Devices and methods for regio-specific drug release at ileocecal region
|
|
GB201919081D0
|
|
Inhaler system
|
|
GB201919076D0
|
|
Inhaler system
|
|
GB201919070D0
|
|
Inhaler system
|
|
WO2020049521A1
|
|
Medroxyprogesterone acetate injectable compositions and methods of use
|
|
CN111194312A
|
|
Novel salts and solid state forms of escitalopram
|
|
US2020281939A1
|
|
Medroxyprogesterone acetate injectable compositions and methods of use
|
|
WO2019040567A1
|
|
Ribociclib salts and solid state forms thereof
|
|
EP3664990A1
|
|
Method and an apparatus for feeding a filament and use of the apparatus for production of a pharmaceutical dosage form
|
|
WO2019028144A1
|
|
Salts and solid state forms of plinabulin
|
|
WO2018067805A1
|
|
Solid state forms of sotagliflozin
|
|
WO2018053109A1
|
|
Gene expression characterization of a glatiramer acetate related drug product in mammalian and human cells
|
|
EP3678637A1
|
|
Medroxyprogesterone acetate injectable compositions and methods of use
|
|
US2019071426A1
|
|
Solid state forms of Nilotinib salts
|
|
WO2017149492A1
|
|
Medroxyprogesterone acetate injectable compositions and methods of use
|
|
GB201700727D0
|
|
Inhalers and airflow adaptors therefor
|
|
US2018200202A1
|
|
Pre-filled syringe
|
|
WO2017120355A1
|
|
Dihydroquinolines and uses thereof
|
|
EA028561B1
|
|
Solid dosage forms of tadalafil
|
|
GB201621275D0
|
|
Medical injection device packaging
|
